BioCryst Pharmaceuticals
BCRX
#4493
Rank
ยฃ1.74 B
Marketcap
ยฃ6.96
Share price
-1.57%
Change (1 day)
30.26%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): ยฃ0.19 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ0.87 Billion. , an increase over its 2024 earnings that were of -ยฃ64.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.19 B-407.51%
2024 -ยฃ64.33 Million-61.56%
2023 -ยฃ0.17 Billion-7.43%
2022 -ยฃ0.19 Billion34.42%
2021 -ยฃ0.14 Billion-0.55%
2020 -ยฃ0.14 Billion67.88%
2019 -ยฃ80.56 Million7.55%
2018 -ยฃ74.9 Million53.92%
2017 -ยฃ48.66 Million19.29%
2016 -ยฃ40.8 Million28.19%
2015 -ยฃ31.83 Million-4.8%
2014 -ยฃ33.43 Million50.09%
2013 -ยฃ22.28 Million-23.29%
2012 -ยฃ29.04 Million-26.19%
2011 -ยฃ39.34 Million54.78%
2010 -ยฃ25.42 Million150.1%
2009 -ยฃ10.17 Million-49.43%
2008 -ยฃ20.1 Million14.07%
2007 -ยฃ17.62 Million-49.31%
2006 -ยฃ34.76 Million72.87%
2005 -ยฃ20.11 Million22.08%
2004 -ยฃ16.47 Million75.3%
2003 -ยฃ9.4 Million-25.36%
2002 -ยฃ12.59 Million225.05%
2001 -ยฃ3.88 Million-56.6%
2000 -ยฃ8.93 Million50.63%
1999 -ยฃ5.93 Million38.05%
1998 -ยฃ4.3 Million-52.46%
1997 -ยฃ9.03 Million58.44%
1996 -ยฃ5.7 Million-14.44%
1995 -ยฃ6.66 Million28.57%
1994 -ยฃ5.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
ยฃ7.24 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ7.31 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-ยฃ0.19 Billion-194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ62.05 M-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.27 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-ยฃ6.02 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ18.32 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA